LTR Pharma Ltd (LTP) — Tangible Net Worth Ratio

Latest as of December 2025: 100.0%

LTR Pharma Ltd (LTP) has a Tangible Net Worth Ratio of 100.0% as of December 2025. This metric is calculated by deducting intangible assets (AU$0.00) from net assets (AU$26.86 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. For live market cap and overall valuation, see LTR Pharma Ltd market cap and net worth.

Tangible NW Ratio

100.0%
Tangible equity / total equity

Net Assets (Equity)

AU$26.86 Million
AUD

Intangible Assets

AU$0.00
Goodwill, patents, brand value

Total Assets

AU$27.32 Million
AUD

LTR Pharma Ltd Tangible Net Worth Ratio (2022–2025)

This chart shows how LTR Pharma Ltd's Tangible Net Worth Ratio has changed across 4 annual periods from 2022 to 2025. As of December 2025, the ratio stands at 100.0%, reflecting net assets of AU$26.86 Million with intangible assets of AU$0.00 AUD. Also explore LTR Pharma Ltd equity growth rate to track the company's year-over-year net asset growth rate.

Annual Tangible Net Worth Ratio for LTR Pharma Ltd (2022–2025)

The table below presents the year-by-year Tangible Net Worth Ratio for LTR Pharma Ltd from 2022 to 2025, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See LTR Pharma Ltd free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.

Year Tangible NW Ratio Net Assets (AUD) Intangible Assets Total Assets Change (pp)
2025 100.0% AU$31.51 Million AU$0.00 AU$32.21 Million ▲ +0.0 pp
2024 100.0% AU$2.94 Million AU$0.00 AU$3.37 Million ▲ +0.0 pp
2023 100.0% AU$2.07 Million AU$0.00 AU$2.09 Million ▲ +0.0 pp
2022 100.0% AU$1.77 Million AU$0.00 AU$2.25 Million
pp = percentage points